MT2 powder(abbreviated as Melanotan II or MT-II powder) is an artificially synthesized structural analog of α-melanocyte-stimulating hormone (α-MSH). Due to its high molecular homology with endogenous α-MSH, it possesses the biological activity of precisely targeting and binding to various melanocortin receptors in the human body. Its fundamental physiological functions revolve around the regulation of melanocytes. It can specifically activate the melanocortin 1 receptor (MC1R) on the surface of melanocytes, initiating intracellular signal cascades to accelerate the synthesis and secretion of melanin, thereby inducing skin pigmentation. This was one of the core research objectives during its initial development.
However, it is noteworthy that the biological effects of MT2 are not limited to pigment regulation. Its broad-spectrum binding capability to the melanocortin receptor family, owing to its molecular structure, enables it to efficiently bind to receptors other than MC1R (particularly MC3R and MC4R), triggering a series of diverse physiological responses. Among these, its potential for regulating specific functions has become a key focus of preclinical research in recent years, offering a new perspective for exploring potential interventions for sexual dysfunction.
We not only provide powder, but also other dosage forms. If necessary, please contact our sales team.
Our Products Form






MT2 COA



MT2 powder, through specific binding with these two types of receptors, can penetrate the blood-brain barrier to act on central neural pathways, regulating the secretion of neurotransmitters and hormonal balance associated with sexual desire and arousal. Simultaneously, it can target peripheral reproductive tissues such as the corpus cavernosum of the penis, participating in the regulation of vasodilation and smooth muscle function. This forms a coordinated regulatory network involving both central and peripheral mechanisms, establishing the core biological basis for its role in improving sexual function. This distinct mechanism also sets it apart from traditional sexual function interventions that solely target peripheral tissues, highlighting its unique research value.
Improving sexual function by regulating the vasodilation of penile cavernous bodies
Melanotan II (MT-II) regulates vascular dilation in the corpus cavernosum of the penis through a cascade reaction that involves receptor binding → signal transduction → factor release → smooth muscle relaxation. This process operates via peripheral local action and does not rely on direct regulation by the neural center. As a result, MT-II can also exert effects in certain models of neurogenic erectile dysfunction. This mechanism has been validated through animal experiments and in vitro cell studies.

1.Targeted Binding to Melanocortin Receptors in Cavernous Tissue
The penile corpus cavernosum consists of smooth muscle cells, vascular endothelial cells, and connective tissue. As an analog of α-MSH, MT-II can specifically bind to MC3R (melanocortin 3 receptor) and MC4R (melanocortin 4 receptor) on the surface of smooth muscle cells and vascular endothelial cells in the cavernous tissue. These two receptor types belong to the G protein-coupled receptor (GPCR) family and serve as the "molecular switches" for initiating vascular dilation signals by MT-II.
Upon binding of MT-II to MC3R/MC4R, the receptor-coupled Gαs protein is activated. The Gαs protein further activates intracellular adenylate cyclase (AC), promoting the conversion of adenosine triphosphate (ATP) into cyclic adenosine monophosphate (cAMP)-a key second messenger regulating cellular function. Meanwhile, some studies indicate that signaling pathway activation also indirectly facilitates the activation of phospholipase C (PLC), generating inositol triphosphate (IP3) and diacylglycerol (DAG) to enhance subsequent dilation effects.


3.Promoting the Release of the Key Vasodilator – Nitric Oxide (NO)
On one hand, elevated cAMP levels activate protein kinase A (PKA). PKA phosphorylates endothelial nitric oxide synthase (eNOS) in vascular endothelial cells, significantly enhancing eNOS activity and catalyzing the conversion of L-arginine to nitric oxide (NO). On the other hand, the activation of signaling pathways in smooth muscle cells also induces the expression of a small amount of neuronal nitric oxide synthase (nNOS), supplementing NO production. NO is the most critical vasodilator in the penile erection process, rapidly diffusing into neighboring smooth muscle cells to exert its effects.
NO, which diffuses into smooth muscle cells, activates soluble guanylate cyclase (sGC). sGC catalyzes the conversion of guanosine triphosphate (GTP) to cyclic guanosine monophosphate (cGMP). cGMP further activates protein kinase G (PKG), which relaxes cavernous smooth muscle through the following two mechanisms:
Reducing the concentration of calcium ions (Ca²⁺) in smooth muscle cells, thereby inhibiting calcium-dependent myosin contraction.
Enhancing the activity of myosin light chain phosphatase, accelerating myosin dephosphorylation, and alleviating the contracted state of smooth muscle.After smooth muscle relaxation, the vascular spaces within the cavernous tissue expand, allowing blood to rapidly flow into and fill the corpus cavernosum, thereby achieving penile erection.

The regulatory role of the MT2 central nervous system pathway
In addition to its direct vasodilatory regulatory effects on peripheral tissues such as the penile corpus cavernosum, Melanotan II (MT-II), leveraging its structural advantage as a small peptide molecule, can effectively cross the blood-brain barrier. It specifically targets melanocortin 3 receptors (MC3R) and melanocortin 4 receptors (MC4R) within the central nervous system, achieving central-level regulation of sexual function through the activation of these receptors. This mechanism can be detailed in two key aspects:
First, it regulates the balance of neurotransmitters related to sexual desire. Activation of these receptors significantly upregulates dopamine levels in the central nervous system, which governs sexual motivation and desire expression. Concurrently, it moderately modulates the release efficiency of norepinephrine and suppresses the activity of inhibitory neurotransmitters such as gamma-aminobutyric acid (GABA), thereby alleviating the inhibition of sexual excitation signals.
Second, it enhances the central nervous system's ability to integrate and respond to sexual stimuli. Activated MC3R/MC4R can strengthen the recognition and transmission efficiency of sexual stimuli in key brain regions such as the hypothalamus and brainstem, shortening the response latency of the central nervous system. This, in turn, indirectly improves the sensitivity and reaction speed of sexual arousal in the body.

As crucial members of the melanocortin receptor family, MC3R and MC4R are widely distributed in both the central nervous system and peripheral reproductive tissues of the human body. Their functional activities are directly linked to the regulation of sexual desire, sexual signaling, and the physiological state of reproductive tissues. Through specific binding with these two receptor types, MT-II can cross the blood-brain barrier to act on central neural pathways, regulating the secretion of neurotransmitters and hormonal balance associated with sexual desire and arousal.
Simultaneously, it can target peripheral reproductive tissues such as the penile corpus cavernosum, participating in the regulation of vasodilation and smooth muscle function. This coordinated central-peripheral regulatory network establishes the core biological foundation for its role in improving sexual function. This distinct mechanism also sets it apart from traditional sexual function interventions that solely target peripheral tissues, highlighting its unique research value.

In summary, the core mechanism by which Melanotan II (MT-II) improves sexual function is achieved through targeted binding to melanocortin receptors (MCRs), with a particular focus on MC3R and MC4R, thereby establishing a synergistic central and peripheral regulatory network. Current research in this field is primarily concentrated on male erectile dysfunction. As key members of the melanocortin receptor family, MC3R and MC4R are widely distributed in both the central nervous system and peripheral reproductive tissues of the human body. Their functional activities are directly linked to the regulation of sexual desire, sexual signaling, and the physiological state of reproductive tissues.
Through specific binding with these two receptor types, MT-II can penetrate the blood-brain barrier to modulate the secretion of central neurotransmitters and hormonal balance, while also targeting peripheral reproductive tissues such as the corpus cavernosum of the penis, participating in the regulation of vasodilation and smooth muscle function. This unique dual-action mechanism not only lays the core foundation for its ability to improve sexual function but also distinguishes it from traditional interventions that solely target peripheral tissues, underscoring its significant research value.
3 Future Prospects
Deepening Mechanistic Research and Expanding Application Boundaries
Further clarify the differential regulatory mechanisms of MC3R/MC4R in central and peripheral pathways, and explore the potential value of MT-II in intervening in female sexual dysfunction.
Advancing Clinical Translation and Optimizing Formulation Development
Conduct standardized clinical trials to validate safety and efficacy, optimize dosing regimens and formulation compositions, and facilitate its transition into a compliant therapeutic drug.
Enhancing Safety Evaluation and Strengthening Application Safeguards
Systematically investigate the dose-dependent side effects and drug interactions associated with long-term use, establish a comprehensive safety evaluation system, and mitigate risks related to endocrine and pigment metabolism.
Hot Tags: mt2 powder, China mt2 powder manufacturers, suppliers, salcatonin injection, intranasal desmopressin acetate, best glp 1 peptide, inj calcitonin, glp1 shot, etelcalcetide structure

